PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Cancer Center, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, USA janowitz@cshl.edu KJTracey@northwell.edu dtuveson@cshl.edu.\', \'Northwell Health Cancer Institute, New Hyde Park, New York, USA.\', \'Cancer Center, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, USA.\', \'Medical Faculty, Ruprecht-Karls-University Heidelberg, Heidelberg, Germany.\', \'Department of Zoology, University of Cambridge, Cambridge, United Kingdom.\', \'Columbia University Medical Center, New York City, New York, USA.\', \'Divion of General Internal Medicine, Department of Medicine, Manhasset, New York, USA.\', \'The Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York, USA.\', \'The Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York, USA janowitz@cshl.edu KJTracey@northwell.edu dtuveson@cshl.edu.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1136/gutjnl-2020-321852
?:doi
?:hasPublicationType
?:journal
  • Gut
is ?:pmid of
?:pmid
?:pmid
  • 32499303
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 7.44
?:rankingScore_hIndex
  • 251
?:title
  • Famotidine use and quantitative symptom tracking for COVID-19 in non-hospitalised patients: a case series.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all